설명

Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. To accomplish occlusion, embolotherapy uses minimally-invasive techniques and various embolic agents, such as gelfoam, coils, balloons and angiographic catheters to achieve precise and significant results. The global embolotherapy market is set to grow by US$ 1.50 10억 동안 2021-2027, 연평균 성장률로 성장 (CAGR) ~의 6.6% 예측 기간 동안, 데이터 및 분석 회사 StrategyHelix에 따르면. Growing target population, expanding applications of embolotherapy devices, escalating prevalence of chronic and lifestyle-associated diseases, increasing healthcare expenditure, and improving healthcare infrastructure are expected to boost the market growth in the coming years.

이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2017-2020 그리고 예측 2027 covering key market aspects like sales value for embolotherapy. The global embolotherapy market is segmented on the basis of product, indication, procedure, 지역, 그리고 최종 사용자. 제품별, it is categorized into embolic agents, and support devices. The embolic agents segment held the largest market share in 2020. By indication, the embolotherapy market is divided into cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders. The cancer segment accounted for the largest market share in 2020. Based on procedure, the embolotherapy market is divided into transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy. Embolotherapy market by region is divided into North America, 아시아 태평양, 유럽, 및 기타 국가 (열).

The report has profiled some of the key players of the market such as Acandis GmbH, Balt Extrusion SAS, 보스턴 사이언티픽 코퍼레이션, Cook Group Incorporated, Guerbet SA, 존슨 & 존슨, Kaneka Corporation, 메드트로닉 PLC, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Stryker Corporation, Terumo Corporation.

이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the embolotherapy market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.

보고 범위

제품: embolic agents, and support devices
Indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders
Procedure: transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy
최종 사용자: hospitals and clinics, ambulatory surgical centers (ascs), 다른 사람
지역: 북아메리카, 아시아 태평양, 유럽, 및 기타 국가 (열)
고려한 연도: 이 보고서는 기간을 다룹니다 2017 에게 2027

이해관계자를 위한 주요 이점

Get a comprehensive picture of the global embolotherapy market
현지 데이터 및 분석을 기반으로 지역 전략 및 전략적 우선순위 파악
성장 분야 및 투자 동향 파악
Understand what the future of the global embolotherapy market looks like
경쟁 구도 및 기회의 창 식별

목차

1. 시장 정의
2. 연구 방법론
3. 시장 데이터 & 시야
3.1 시장 가치
3.2 시장 가치 예측
4. Embolotherapy Market by Product
4.1 Embolic Agents
4.2 Support Devices
5. Embolotherapy Market by Indication
5.1 Cancer
5.2 Neurological Diseases
5.3 Peripheral Vascular Diseases
5.4 Urological And Nephrological Disorders
5.5 Gastrointestinal Disorders
6. Embolotherapy Market by Procedure
6.1 Transcatheter Arterial Embolization
6.2 Transarterial Chemoembolization
6.3 Transarterial Radioembolization/Selective Internal Radiation Therapy
7. Embolotherapy Market by Region
7.1 북아메리카
7.2 아시아 태평양
7.3 유럽
7.4 나머지 세계 (열)
8. Embolotherapy Market by End User
8.1 Hospitals And Clinics
8.2 Ambulatory Surgical Centers (Ascs)
8.3 기타
9. 회사 프로필
9.1 Acandis GmbH
9.2 Balt Extrusion SAS
9.3 보스턴 사이언티픽 코퍼레이션
9.4 Cook Group Incorporated
9.5 Guerbet SA
9.6 존슨 & 존슨
9.7 Kaneka Corporation
9.8 메드트로닉 PLC
9.9 Meril Life Sciences Private Limited
9.10 Merit Medical Systems Inc.
9.11 Penumbra, 주식회사.
9.12 Sirtex Medical Limited
9.13 Stryker Corporation
9.14 Terumo Corporation
10. 부록
10.1 스트래티지헬릭스 소개
10.2 부인 성명